Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Checkpoint Blockade”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03639714
What this trial is testing

A Personalized Neoantigen Cancer Vaccine

Who this might be right for
Non Small Cell Lung CancerColorectal CancerGastroesophageal Adenocarcinoma+1 more
Gritstone bio, Inc. 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT03610711
What this trial is testing

REACTION (Radiation Enhanced Assessment of Combination Therapies in Immuno-ONcology) - Nivolumab or Nivolumab in Combination With Other Immuno-oncology (IO) Agents After Targeted Systemic Radiation in Patients With Advanced Esophagogastric Cancer

Who this might be right for
Gastroesophageal CancerImmune Checkpoint Inhibition
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 21
Early research (Phase 1)Active Not RecruitingNCT03955978
What this trial is testing

TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial Cancer

Who this might be right for
Endometrial CancerCancer of the Endometrium
Washington University School of Medicine 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT04543071
What this trial is testing

Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic CancerAdenocarcinoma of the PancreasAdenocarcinoma
Columbia University 118
Not applicableActive Not RecruitingNCT03291028
What this trial is testing

Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

Who this might be right for
Renal Cell CarcinomaUrothelial CarcinomaBladder Cancer+2 more
Fox Chase Cancer Center 15
Testing effectiveness (Phase 2)Study completedNCT03721757
What this trial is testing

CA209-891: Neoadjuvant and Adjuvant Nivolumab as Immune Checkpoint Inhibition in Oral Cavity Cancer

Who this might be right for
Squamous Cell Carcinoma of the Oral Cavity
The Clatterbridge Cancer Centre NHS Foundation Trust 21
Not applicableLooking for participantsNCT05973344
What this trial is testing

Understanding and Anticipating Therapeutic and ADverse Responses in Anti-cancer Immune Checkpoint Inhibition Towards a Better Therapeutic Management of Patients

Who this might be right for
Cancer
University Hospital, Brest 200
Early research (Phase 1)WithdrawnNCT02868632
What this trial is testing

Study of Immune Checkpoint Inhibition With Radiation Therapy in Unresectable, Non-metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
NYU Langone Health
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07103408
What this trial is testing

A Study Evaluating Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade for Limited-stage Small Cell Lung Cancer

Who this might be right for
Small-Cell Lung Cancer (SCLC)
Sun Yat-sen University 56
Testing effectiveness (Phase 2)Looking for participantsNCT05915442
What this trial is testing

Adenosine Signaling Modulation and Immune Checkpoint Inhibition With Hormone Sensitive Oligometastatic Prostate Cancer

Who this might be right for
Oligometastatic Prostate Cancer
Catherine Spina 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT03734692
What this trial is testing

Systemic Immune Checkpoint Blockade and Intraperitoneal Chemo-Immunotherapy in Recurrent Ovarian Cancer

Who this might be right for
Ovarian Cancer Recurrent
Robert Edwards 24
Testing effectiveness (Phase 2)Looking for participantsNCT06048484
What this trial is testing

Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Gulam Manji 60
Testing effectiveness (Phase 2)Ended earlyNCT04560686
What this trial is testing

Bintrafusp Alfa Before Surgery for the Treatment of Untreated Resectable Non-small Cell Lung Cancer

Who this might be right for
Resectable Lung Non-Small Cell CarcinomaStage I Lung Cancer AJCC v8Stage IA1 Lung Cancer AJCC v8+8 more
M.D. Anderson Cancer Center 2
Testing effectiveness (Phase 2)Looking for participantsNCT05284539
What this trial is testing

Efficacy of Platinum-based Chemotherapy Plus Immune Checkpoint Inhibitors for EGFR/ALK/ROS1 Mutant Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Hunan Province Tumor Hospital 760
Testing effectiveness (Phase 2)Active Not RecruitingNCT03076554
What this trial is testing

A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based Chemotherapy

Who this might be right for
ThymomaThymic Carcinoma
National Cancer Institute (NCI) 56
Not applicableStudy completedNCT03453892
What this trial is testing

Investigation of the Timely-coordinated Therapy of Patients With Metastatic Cancer by Radiotherapy Together With Immune Checkpoint Inhibition

Who this might be right for
Metastatic Cancer
University of Erlangen-Nürnberg Medical School 150
Early research (Phase 1)WithdrawnNCT03802747
What this trial is testing

Immunotherapy Combined With Y-90 and SBRT for Colorectal Liver Metastases

Who this might be right for
Colorectal Cancer
University of Colorado, Denver
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06538935
What this trial is testing

SBRT Combined With Adbelimumab and Apatinib for Perioperative and Conversion Therapy of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaSBRTImmune Checkpoint Blockade+1 more
Fujian Cancer Hospital 80
Testing effectiveness (Phase 2)Study completedNCT03365791
What this trial is testing

PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies

Who this might be right for
Small Cell Lung CancerGastric AdenocarcinomaEsophageal Adenocarcinoma+5 more
Novartis Pharmaceuticals 76
Not applicableLooking for participantsNCT07064681
What this trial is testing

The Real-world Study of AK104 Combining With TACE for Resectable Hepatocellular Carcinoma (MORNING)

Who this might be right for
Resectable Hepatocellular Carcinoma With High Risk of Recurrence
Sun Yat-sen University 100
Next Page